Royal Bank of Canada’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-173,945
| Closed | -$51K | – | 7229 |
|
2023
Q3 | $51K | Buy |
173,945
+55,185
| +46% | +$16.2K | ﹤0.01% | 5293 |
|
2023
Q2 | $57K | Sell |
118,760
-4,368
| -4% | -$2.1K | ﹤0.01% | 5270 |
|
2023
Q1 | $78K | Buy |
123,128
+4,878
| +4% | +$3.09K | ﹤0.01% | 4986 |
|
2022
Q4 | $54K | Buy |
118,250
+112,501
| +1,957% | +$51.4K | ﹤0.01% | 5365 |
|
2022
Q3 | $5K | Buy |
5,749
+424
| +8% | +$369 | ﹤0.01% | 6276 |
|
2022
Q2 | $6K | Sell |
5,325
-6,506
| -55% | -$7.33K | ﹤0.01% | 6143 |
|
2022
Q1 | $15K | Buy |
11,831
+978
| +9% | +$1.24K | ﹤0.01% | 6290 |
|
2021
Q4 | $18K | Sell |
10,853
-37,436
| -78% | -$62.1K | ﹤0.01% | 6318 |
|
2021
Q3 | $134K | Buy |
48,289
+32,312
| +202% | +$89.7K | ﹤0.01% | 4991 |
|
2021
Q2 | $48K | Buy |
15,977
+4,549
| +40% | +$13.7K | ﹤0.01% | 5585 |
|
2021
Q1 | $47K | Sell |
11,428
-11,999
| -51% | -$49.3K | ﹤0.01% | 5432 |
|
2020
Q4 | $110K | Buy |
+23,427
| New | +$110K | ﹤0.01% | 4752 |
|